IVWATCH - Key Persons
Erin Wendell, the Chief Marketing Officer at ivWatch, leads the strategic vision and direction for ivWatch's global branding and messaging, digital presence, internal and external communications and experiential marketing. Erin oversees all aspects of the company's global brand marketing strategy. Erin has successfully built global marketing communications initiatives, directives and experiences for nearly 15 years.
Prior to beginning work at ivWatch, she served as the Senior Director of Global Communications at Under Armour. At Under Armour, she played a critical role in growing the communications function from its inception, driving brand awareness, executing entries into global markets, launching major campaigns and products and establishing best in class media and employee communications practices.
Gary Warren currently serves as president and CEO of ivWatch and has championed the development of non-invasive biosensors that fulfill a huge patient safety need in health care. Starting ivWatch in 2010, Gary assembled a team of leading scientists, clinicians, hospitals and investors to solve a common drug delivery problem of IV infiltration and extravasation. Gary has guided ivWatch through multiple ISO audits and FDA clearances for this breakthrough technology with ivWatch products now being sold on the international market.
Gary has a multidisciplinary background with a 14-year career as a research scientist at NASA in aerospace and computational fluid dynamics. He departed NASA to start a successful Internet infrastructure company in the mid-1990s and served as CEO until it's sale to Symantec in 1999. At Symantec, Gary served as a senior vice president and oversaw advanced technologies, mergers and acquisitions and gateway software products. He also served as a member of the senior executive staff. After Symantec, Gary served as CEO for a venture-backed mobile platform company as smartphones were beginning to emerge as a market. After the sale of this company to Oracle, Gary worked for various venture capital companies doing financial analysis and due diligence which brought him to the work being done on IV infiltrations under a National Institutes of Health (NIH) grant. Since bringing over the core engineering talent and founding the company, Gary has grown ivWatch to an award-winning brand in health care that is setting a new standard in IV therapy care.
Job Titles:
- Vice President of International Sales, EMEA
Helen Stephens, the Vice President of International Sales, EMEA at ivWatch, leads the company's international expansion plans from the United Kingdom. She is responsible for directing the international distributor program and paving the way into new markets. She provides a wealth of knowledge to drive growth in the EMEA region and select other global high-demand markets.
She has a tenured 30-year diverse career, as a nurse at the bedside and with experience in medical device sales at companies including Becton Dickinson, Vygon, Smiths Medical, and most recently ICU Medical, where she served as the Infusion Product Sales Manager, EMEA. In her career, Helen has held various leadership roles in Sales, Business Development, and Clinical. Helen is a registered general nurse and holds a degree from Frances Harrison College of Healthcare, University of Surrey.
Job Titles:
- VP, Regulatory Affairs and Quality Assurance
Holly Novak is responsible for ensuring compliance to all applicable standards and leads the ivWatch Quality Management System (QMS). Prior to joining ivWatch, Holly has spent the past 15 years in various roles within R&D, Production and Quality Assurance for products that required both USDA and FDA clearance.
In her most recent positions, Holly implemented and maintained an ISO compliant Quality Management System for a medical device company, and more recently for a global supplier of raw materials that served the pharmaceutical, device, government agencies and university markets. She also played an instrumental role in attaining CE marking for the entire product line for Maine Standards Company, a market leader for linearity and calibration verification products.
Jaclyn Lautz is responsible for oversight of research and development, manufacturing, human resources and operations. She leads all product development and innovation efforts for ivWatch, including directing the engineering teams on the design and development of new products and working across departments to bring new products to the market.
Jaclyn joined ivWatch in 2018 from Pricewaterhouse Coopers (PwC) where she was an advisory manager in the pharmaceutical and life sciences operations practice. Prior to that, Jaclyn was ivWatch's Director of Regulatory Affairs & Quality Assurance and also held several biomedical engineer positions. Jaclyn has a Ph.D. in mechanical engineering & materials science from Duke University where she worked with industry partners on new medical devices and treatment strategies for urological diseases. Her work is published in several physics and medical journals. She was awarded the NSF Graduate Research Fellowship and the NSF Engineering Innovation Fellowship for her graduate studies at Duke University.
Kathy Cox is the Chief Financial Officer overseeing the accounting and finance functions at ivWatch. She joined the company in June 2021 with a history of helping businesses drive growth and implementing operational improvements while building strong and efficient teams. Kathy brings an array of professional financial and operational experiences with companies privately owned and those held by global publicly-traded parent companies. Her industry experience includes medical device manufacturing, healthcare, software, and public accounting. Kathy is a CPA with over 23 years of experience, with the past 15 years spent in the medical device manufacturing and healthcare markets.
Prior to joining ivWatch, Kathy held a series of executive positions for 12 years within Solesis, an operating division of Michelin and Fenner PLC, including Director/General Manager and Finance Director at Charter Medical and Finance Director at Xeridiem Medical Devices.